Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

NCT02226146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Pemphigoid, Bullous

Interventions

BIOLOGICAL: Bertilimumab

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]